Balaji Gandhi Sells 28,759 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) CFO Balaji Gandhi sold 28,759 shares of the firm's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $30.00, for a total value of $862,770.00. Following the sale, the chief financial officer now directly owns 116,174 shares in the company, valued at $3,485,220. The trade was a 19.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Tuesday, February 18th, Balaji Gandhi sold 5,771 shares of Phreesia stock. The stock was sold at an average price of $30.04, for a total value of $173,360.84.
• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total value of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $85,018.95.

Phreesia Stock Performance

Phreesia stock traded down $0.27 during midday trading on Friday, reaching $28.20. 500,095 shares of the company's stock were exchanged, compared to its average volume of 364,321. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The firm has a market cap of $1.64 billion, a price-to-earnings ratio of -19.18 and a beta of 0.96. The stock's 50-day simple moving average is $27.29 and its 200 day simple moving average is $23.84.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts' consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business had revenue of $106.80 million during the quarter, compared to analysts' expectations of $106.33 million. During the same quarter last year, the company posted ($0.58) earnings per share. Phreesia's quarterly revenue was up 16.6% on a year-over-year basis. On average, analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on PHR shares. Robert W. Baird lowered their target price on Phreesia from $34.00 to $30.00 and set an "outperform" rating for the company in a report on Wednesday, December 11th. JMP Securities reiterated a "market outperform" rating and set a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Truist Financial increased their target price on Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a report on Wednesday, December 11th. Royal Bank of Canada upgraded Phreesia from a "sector perform" rating to an "outperform" rating and increased their target price for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. Finally, Citigroup increased their target price on Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a report on Friday, January 10th. Thirteen analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $31.15.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently bought and sold shares of PHR. Johnson Financial Group Inc. lifted its position in Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after acquiring an additional 896 shares during the last quarter. R Squared Ltd acquired a new stake in Phreesia during the fourth quarter worth approximately $30,000. International Assets Investment Management LLC lifted its position in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock worth $33,000 after acquiring an additional 1,395 shares during the last quarter. BankPlus Trust Department acquired a new stake in Phreesia during the fourth quarter worth approximately $34,000. Finally, Quarry LP lifted its position in Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock worth $71,000 after acquiring an additional 1,923 shares during the last quarter. Institutional investors own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.